Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas (Q39467184)

12 September 2017

Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas (English)

1 reference

12 September 2017

3

1 reference

12 September 2017

Marco Giaisi

1

1 reference

12 September 2017

Rebecca Köhler

series ordinal

2

1 reference

12 September 2017

Peter H Krammer

series ordinal

4

1 reference

12 September 2017

Min Li-Weber

series ordinal

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

8 November 2011

1 reference

International Journal of Cancer

12 September 2017

1 reference

12 September 2017

131

1 reference

12 September 2017

4

1 reference

12 September 2017

1003-1008

1 reference

From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential

12 September 2017

1 reference

Emerging drugs for Hodgkin's lymphoma

21 January 2018

1 reference

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

The TRAIL apoptotic pathway in cancer onset, progression and therapy

21 January 2018

1 reference

c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis

21 January 2018

1 reference

Life and death in peripheral T cells

21 January 2018

1 reference

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

Cell death in hematological tumors

21 January 2018

1 reference

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

21 January 2018

1 reference

Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression

21 January 2018

1 reference

Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.

21 January 2018

1 reference

IAP-targeted therapies for cancer

21 January 2018

1 reference

Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer

21 January 2018

1 reference

Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas

21 January 2018

1 reference

Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail

21 January 2018

1 reference

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

21 January 2018

1 reference

Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis

21 January 2018

1 reference

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

21 January 2018

1 reference

Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death

21 January 2018

1 reference

Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells

21 January 2018

1 reference

The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities

21 January 2018

1 reference

Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression

21 January 2018

1 reference

Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26458

1 reference

12 September 2017

1 reference